Clinical pharmacology and therapeutics in South Korea: 30 years with the Korean Society of Clinical Pharmacology and Therapeutics.
作者信息
Kim Tae-Eun, Yoon Young-Ran
机构信息
Department of Clinical Pharmacology, Konkuk University Medical Center, Seoul 05029, Korea.
Korean Society of Clinical Pharmacology and Therapeutics, Seoul 04143, Korea.
出版信息
Transl Clin Pharmacol. 2024 Sep;32(3):115-126. doi: 10.12793/tcp.2024.32.e12. Epub 2024 Sep 23.
Abstract
摘要
相似文献
1
Clinical pharmacology and therapeutics in South Korea: 30 years with the Korean Society of Clinical Pharmacology and Therapeutics.韩国的临床药理学与治疗学：与韩国临床药理与治疗学会共同走过的30年
Transl Clin Pharmacol. 2024 Sep;32(3):115-126. doi: 10.12793/tcp.2024.32.e12. Epub 2024 Sep 23.
2
Issues and problems of adaptation of North Korean defectors to South Korean society: an in-depth interview study with 32 defectors.朝鲜叛逃者融入韩国社会的问题与困境：对32名叛逃者的深度访谈研究
Yonsei Med J. 2000 Jun;41(3):362-71. doi: 10.3349/ymj.2000.41.3.362.
3
Health Behavior and Factors Associated with Depression in North Korean Adolescent Defectors in South Korea: The Korea Youth Risk Behavior Web-Based Survey, 2011-2014.韩国境内朝鲜青少年叛逃者的健康行为及与抑郁相关的因素：2011 - 2014年韩国青少年危险行为网络调查
Korean J Fam Med. 2017 Sep;38(5):256-262. doi: 10.4082/kjfm.2017.38.5.256. Epub 2017 Sep 22.
4
5
6
A small window into the status of malaria in North Korea: estimation of imported malaria incidence among visitors from South Korea.朝鲜疟疾状况的一扇小窗：从韩国入境游客中估算输入性疟疾病例。
Epidemiol Health. 2020;42:e2020068. doi: 10.4178/epih.e2020068. Epub 2020 Nov 21.
7
Characteristics of Body Composition and Muscle Strength of North Korean Refugees during South Korean Stay.韩国停留期间朝鲜难民的身体成分和肌肉力量特征。
Endocrinol Metab (Seoul). 2015 Dec;30(4):551-6. doi: 10.3803/EnM.2015.30.4.551. Epub 2015 Oct 20.
8
Trends in South Korean Medical Device Development for Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: Narrative Review.韩国注意力缺陷/多动障碍和自闭症谱系障碍医疗器械开发趋势：叙述性综述
JMIR Biomed Eng. 2024 Oct 15;9:e60399. doi: 10.2196/60399.
9
10
Correlates of depressive symptoms among North Korean refugees adapting to South Korean society: the moderating role of perceived discrimination.适应韩国社会的朝鲜难民抑郁症状的相关因素：感知歧视的调节作用。
Soc Sci Med. 2015 Apr;131:107-13. doi: 10.1016/j.socscimed.2015.02.039. Epub 2015 Feb 26.
本文引用的文献
1
Pharmacokinetic interactions between fexuprazan, a potassium-competitive acid blocker, and nonsteroidal anti-inflammatory drugs in healthy males.钾离子竞争性酸阻滞剂非布司他与非甾体抗炎药在健康男性中的药代动力学相互作用。
Clin Transl Sci. 2024 May;17(5):e13798. doi: 10.1111/cts.13798.
2
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes.肾功能对强效选择性钠-葡萄糖协同转运蛋白2抑制剂恩格列净在2型糖尿病中的药代动力学和药效学的影响。
Diabetes Obes Metab. 2024 Jul;26(7):2588-2597. doi: 10.1111/dom.15573. Epub 2024 Apr 15.
3
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.与AS03佐剂联合使用的SARS-CoV-2重组蛋白纳米颗粒疫苗GBP510的免疫原性和安全性：一项随机、活性对照、观察者盲法3期试验的中期结果
EClinicalMedicine. 2023 Sep 7;64:102140. doi: 10.1016/j.eclinm.2023.102140. eCollection 2023 Oct.
4
Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective.真实世界数据和真实世界证据在药物研发与审批中的临床药理学应用——行业视角
Clin Pharmacol Ther. 2023 Oct;114(4):751-767. doi: 10.1002/cpt.2988. Epub 2023 Jul 29.
5
Pharmacokinetic and pharmacodynamic exploration of various combinations of tegoprazan immediate and delayed-release formulations.替戈拉赞速释和缓释制剂不同组合的药代动力学和药效学研究。
Br J Clin Pharmacol. 2023 Sep;89(9):2877-2887. doi: 10.1111/bcp.15784. Epub 2023 Jun 1.
6
Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects.新型钾离子竞争性抑制剂非布司他与阿司匹林在健康受试者中的药效学和药代动力学药物相互作用
Pharmaceutics. 2023 Feb 7;15(2):549. doi: 10.3390/pharmaceutics15020549.
7
The potential and pitfalls of artificial intelligence in clinical pharmacology.人工智能在临床药理学中的潜力与陷阱。
CPT Pharmacometrics Syst Pharmacol. 2023 Mar;12(3):279-284. doi: 10.1002/psp4.12902. Epub 2023 Jan 30.
8
The next generation of evidence-based medicine.循证医学的下一代。
Nat Med. 2023 Jan;29(1):49-58. doi: 10.1038/s41591-022-02160-z. Epub 2023 Jan 16.
9
Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer.食物和种族对拉泽替尼在健康受试者及表皮生长因子受体（EGFR）突变阳性的晚期非小细胞肺癌患者中药代动力学的影响。
Lung Cancer. 2023 Jan;175:112-120. doi: 10.1016/j.lungcan.2022.11.021. Epub 2022 Dec 2.
10
Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone.肝脏损害对洛格列酮药代动力学特征及安全性的影响。
Clin Pharmacol Drug Dev. 2022 May;11(5):576-584. doi: 10.1002/cpdd.1045. Epub 2022 Mar 7.
Zotero 插件